000 01349 a2200409 4500
005 20250513212118.0
264 0 _c20000925
008 200009s 0 0 eng d
022 _a0268-1315
024 7 _a10.1097/00004850-200015010-00003
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aStamenkovic, M
245 0 0 _aEffective open-label treatment of tourette's disorder with olanzapine.
_h[electronic resource]
260 _bInternational clinical psychopharmacology
_cJan 2000
300 _a23-8 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article
650 0 4 _aAdult
650 0 4 _aAntipsychotic Agents
_xtherapeutic use
650 0 4 _aBenzodiazepines
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aOlanzapine
650 0 4 _aPirenzepine
_xanalogs & derivatives
650 0 4 _aPsychiatric Status Rating Scales
650 0 4 _aTime Factors
650 0 4 _aTourette Syndrome
_xdrug therapy
700 1 _aSchindler, S D
700 1 _aAschauer, H N
700 1 _aDe Zwaan, M
700 1 _aWillinger, U
700 1 _aResinger, E
700 1 _aKasper, S
773 0 _tInternational clinical psychopharmacology
_gvol. 15
_gno. 1
_gp. 23-8
856 4 0 _uhttps://doi.org/10.1097/00004850-200015010-00003
_zAvailable from publisher's website
999 _c10787692
_d10787692